bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 2, 2024
Chromosome
mis-segregation
is
common
in
human
meiosis
and
mitosis,
the
resulting
aneuploidies
are
leading
cause
of
pregnancy
loss.
Preimplantation
genetic
testing
for
aneuploidy
(PGT-A)
seeks
to
prioritize
chromosomally
normal
embryos
transfer
based
on
analysis
a
biopsy
approximately
five
trophectoderm
cells
from
blastocyst-stage
Genome Medicine,
Journal Year:
2023,
Volume and Issue:
15(1)
Published: Oct. 2, 2023
Abstract
Background
The
high
incidence
of
aneuploidy
in
early
human
development,
arising
either
from
errors
meiosis
or
postzygotic
mitosis,
is
the
primary
cause
pregnancy
loss,
miscarriage,
and
stillbirth
following
natural
conception
as
well
vitro
fertilization
(IVF).
Preimplantation
genetic
testing
for
(PGT-A)
has
confirmed
prevalence
meiotic
mitotic
aneuploidies
among
blastocyst-stage
IVF
embryos
that
are
candidates
transfer.
However,
only
about
half
normally
fertilized
develop
to
blastocyst
stage
vitro,
while
others
arrest
at
cleavage
late
morula
stages.
Methods
To
achieve
a
more
complete
view
impacts
aneuploidy,
we
applied
low-coverage
sequencing-based
PGT-A
large
series
(
n
=
909)
arrested
trophectoderm
biopsies.
We
then
correlated
observed
with
abnormalities
first
two
divisions
using
time-lapse
imaging
843).
Results
combined
was
strongly
associated
morphological
grading,
proportion
ranging
20
90%
highest
lowest
grades,
respectively.
In
contrast,
exceptionally
(94%),
dominated
by
affecting
multiple
chromosomes.
turn,
these
were
abnormal
divisions,
such
51%
abnormally
dividing
possessed
compared
23%
embryos.
Conclusions
conclude
combination
drives
development
increasingly
relies
on
embryonic
gene
expression
stage.
Reproductive Biology and Endocrinology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Jan. 17, 2024
Abstract
Background
Several
studies
have
demonstrated
that
iDAScore
is
more
accurate
in
predicting
pregnancy
outcomes
cycles
without
preimplantation
genetic
testing
for
aneuploidy
(PGT-A)
compared
to
KIDScore
and
the
Gardner
criteria.
However,
effectiveness
of
with
PGT-A
has
not
been
thoroughly
investigated.
Therefore,
this
study
aims
assess
association
between
artificial
intelligence
(AI)-based
(version
1.0)
single-embryo
transfer
(SET)
PGT-A.
Methods
This
retrospective
was
approved
by
Institutional
Review
Board
Chung
Sun
Medical
University,
Taichung,
Taiwan.
Patients
undergoing
SET
(
n
=
482)
following
at
a
single
reproductive
center
January
2017
June
2021.
The
blastocyst
morphology
morphokinetics
all
embryos
were
evaluated
using
time-lapse
system.
blastocysts
ranked
based
on
scores
generated
iDAScore,
which
defined
as
AI
scores,
or
D5
3.2)
manufacturer’s
protocols.
A
transferred
after
examining
embryonic
ploidy
status
next-generation
sequencing-based
platform.
Logistic
regression
analysis
generalized
estimating
equations
conducted
whether
are
associated
probability
live
birth
(LB)
while
considering
confounding
factors.
Results
revealed
score
significantly
LB
(adjusted
odds
ratio
[OR]
2.037,
95%
confidence
interval
[CI]:
1.632–2.542)
when
pulsatility
index
(PI)
level
types
chromosomal
abnormalities
controlled.
Blastocysts
divided
into
quartiles
accordance
their
(group
1:
3.0–7.8;
group
2:
7.9–8.6;
3:
8.7–8.9;
4:
9.0–9.5).
Group
1
had
lower
rate
(34.6%
vs.
59.8–72.3%)
higher
loss
(26%
4.7–8.9%)
other
groups
p
<
0.05).
receiver
operating
characteristic
curve
verified
significant
but
limited
ability
predict
(area
under
[AUC]
0.64);
weaker
than
combination
type
abnormalities,
PI
(AUC
0.67).
In
comparison
non-LB
groups,
both
euploid
(median:
8.6
8.8)
mosaic
8.0
8.6)
SETs.
Conclusions
Although
its
predictive
can
be
further
enhanced,
cycles.
Euploid
low
(≤
7.8)
rate,
indicating
potential
annotation-free
system
decision-support
tool
deselecting
poor
Cells,
Journal Year:
2024,
Volume and Issue:
13(12), P. 996 - 996
Published: June 7, 2024
Preimplantation
embryo
culture,
pivotal
in
assisted
reproductive
technology
(ART),
has
lagged
innovation
compared
to
selection
advancements.
This
review
examines
the
persisting
gap
between
vivo
and
vitro
development,
emphasizing
need
for
improved
culture
conditions.
While
humans
this
is
hardly
estimated,
animal
models,
particularly
bovines,
reveal
clear
disparities
developmental
competence,
cryotolerance,
pregnancy
live
birth
rates
vitro-produced
(IVP)
vivo-derived
(IVD)
embryos.
Molecular
analyses
unveil
distinct
differences
morphology,
metabolism,
genomic
stability,
underscoring
refining
conditions
better
ART
outcomes.
To
end,
a
deeper
comprehension
of
oviduct
physiology
transport
crucial
grasping
embryo–maternal
interactions’
mechanisms.
Research
on
autocrine
paracrine
factors,
extracellular
vesicles
tract
interactions,
elucidates
vital
communication
networks
successful
implantation
pregnancy.
In
vitro,
confinement,
density
are
key
factors
boost
development.
Advanced
dynamic
systems
mimicking
fluid
mechanical
stimulation
oviduct,
through
vibration,
tilting,
microfluidic
methods,
use
innovative
softer
substrates,
hold
promise
optimizing
Human Reproduction,
Journal Year:
2023,
Volume and Issue:
39(1), P. 258 - 274
Published: Oct. 23, 2023
Abstract
STUDY
QUESTION
Does
the
diagnosis
of
mosaicism
affect
ploidy
rates
across
different
providers
offering
preimplantation
genetic
testing
for
aneuploidies
(PGT-A)?
SUMMARY
ANSWER
Our
analysis
36
395
blastocyst
biopsies
eight
laboratories
revealed
that
euploidy
were
significantly
higher
in
reporting
low
mosaicism.
WHAT
IS
KNOWN
ALREADY
Diagnoses
consistent
with
chromosomal
have
emerged
as
a
third
category
possible
embryo
outcomes
following
PGT-A.
However,
era
mosaicism,
selection
has
become
increasingly
complex.
Biological,
technical,
analytical,
and
clinical
complexities
interpreting
such
results
led
to
substantial
variability
PGT-A
clinics.
Critically,
it
remains
unknown
whether
these
differences
impact
number
euploid
embryos
available
transfer.
Ultimately,
this
may
outcomes,
important
implications
patients.
DESIGN,
SIZE,
DURATION
In
international,
multicenter
cohort
study,
we
reviewed
consecutive
results,
obtained
from
10
035
patients
11
867
treatment
cycles,
conducted
between
October
2015
2021.
A
total
17
IVF
centers,
providers,
five
countries
three
continents
participated
study.
All
blastocysts
tested
using
trophectoderm
biopsy
next-generation
sequencing.
Both
autologous
donation
cycles
assessed.
Cycles
structural
rearrangements
excluded
analysis.
PARTICIPANTS/MATERIALS,
SETTING,
METHODS
The
randomly
categorized
(A
H).
Providers
B,
C,
D,
E,
F,
G,
H
all
reported
whereas
Provider
either
or
aneuploid.
Ploidy
analyzed
multilevel
mixed
linear
regression.
Analyses
adjusted
maternal
age,
paternal
oocyte
source,
biopsied,
day
biopsy,
provider,
appropriate.
We
compared
associations
including
chromosomally
normal
(euploid)
determined
be
suitable
MAIN
RESULTS
AND
THE
ROLE
OF
CHANCE
mean
age
(±SD)
was
36.2
(±5.2).
findings
reveal
strong
association
provider
Amongst
seven
varied
3.1%
25.0%.
After
adjusting
confounders,
observed
significant
difference
likelihood
diagnosing
(P
<
0.001),
ranging
6.5%
(95%
CI:
5.2–7.4%)
B
35.6%
32.6–38.7%)
E.
Notably,
highest
lowest
(Provider
B:
euploidy,
55.7%
54.1–57.4%),
5.2–7.4%);
H:
44.5%
43.6–45.4%),
9.9%
9.2–10.6%));
D:
43.8%
39.2–48.4%),
11.0%
7.5–14.5%)).
Moreover,
overall
chance
having
at
least
one
transfer
when
not
reported,
other
(OR
=
1.30,
95%
1.13–1.50).
Differences
mosaic
raise
further
concerns
regarding
accuracy
relevance
predictions.
While
confirmed
equivalent
blastocysts,
found
proportion
are
used
treatment.
LIMITATIONS,
REASONS
FOR
CAUTION
Due
retrospective
nature
can
ascertained,
however,
causality
cannot
established.
Certain
parameters
grade
dataset.
Furthermore,
certain
platform-related
clinic-specific
factors
readily
quantifiable
explicitly
captured
our
As
such,
full
elucidation
potential
confounders
accounting
possible.
WIDER
IMPLICATIONS
FINDINGS
highlight
need
standardization
quality
assurance
industry.
decision
ultimately
reduce
success
cycle
by
limiting
pool
embryos.
Until
diagnoses
accurately
reflect
biological
variability,
warrants
utmost
caution.
prudent
approach
is
imperative,
determine
failure
some
FUNDING/COMPETING
INTEREST(S)
This
work
supported
Torres
Quevedo
Grant,
awarded
M.P.
(PTQ2019-010494)
Spanish
State
Research
Agency,
Ministry
Science
Innovation,
Spain.
M.P.,
L.B.,
A.R.L.,
A.L.R.d.C.L.,
N.P.P.,
D.S.,
F.A.,
A.P.,
B.M.,
L.D.,
F.V.M.,
M.R.,
E.P.d.l.B.,
A.R.,
R.V.
no
competing
interests
declare.
B.L.,
R.M.,
J.A.O.
time
employees
IB
Biotech,
genetics
company
Instituto
Bernabeu
group,
which
performs
testing.
M.G.
employee
Novagen,
Cegyr,
TRIAL
REGISTRATION
NUMBER
N/A.
Frontiers in Molecular Biosciences,
Journal Year:
2023,
Volume and Issue:
10
Published: April 14, 2023
Aneuploidy
in
preimplantation
embryos
is
a
major
cause
of
human
reproductive
failure.
Unlike
uniformly
aneuploid
embryos,
diagnosed
as
diploid-aneuploid
mosaics
after
genetic
testing
for
aneuploidy
(PGT-A)
can
develop
into
healthy
infants.
However,
the
reason
why
these
achieve
full
competence
needs
further
research.
Current
RNA
sequencing
techniques
allow
investigation
transcriptome,
providing
new
insights
molecular
mechanisms
embryo
development.
In
this
prospective
study,
using
euploid
gene
expression
control,
we
compared
transcriptome
profiles
inner
cell
mass
and
trophectoderm
samples
from
blastocysts
with
different
levels
chromosomal
mosaicism.
A
total
25
were
analyzed
14
previous
PGT-A
diagnosis,
including
five
low-level
mosaic
four
high-level
embryos.
Global
visualized
cluster
heatmaps
correlated
original
diagnosis.
addition,
distance
based
on
number
differentially
expressed
genes
increased
level,
to
controls.
Pathways
involving
apoptosis,
mitosis,
protein
degradation,
metabolism,
mitochondrial
energy
production
among
most
deregulated
within
Retrospective
analysis
duration
blastomere
cycles
revealed
several
mitotic
delays
controls,
additional
evidence
status.
Overall,
findings
suggest
that
results
are
not
simply
misdiagnosis
by-product,
but
may
also
have
genuine
identity
compatible
their
potential.
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: Sept. 30, 2024
Background
Ovulatory
dysfunction
is
more
common
in
women
with
obesity.
Body
fat
distribution
also
crucial
because
anovulatory
have
a
greater
waist
circumference
and
abdominal
than
ovulatory
of
similar
BMI.
The
primary
aim
the
present
study
to
determine
whether
there
relationship
between
BMI
reproductive
characteristics,
including
hormonal
values,
antral
follicle
count
(AFC),
endometrial
assessment
at
transvaginal
ultrasound
evaluation
(TVUS)
during
controlled
ovarian
stimulation
(COS),
oocyte
retrieval
after
Ovum
Pick-Up
(OPU).
Methods
Data
from
cohort
183
patients
were
analyzed
divided
into
three
groups
based
on
weight
status:
normal
weight,
overweight,
Evaluated
characteristics
included:
age,
basal
values
follicle-stimulating
hormone
(FSH),
luteinizing
(LH),
17-beta-estradiol
(E2),
thyroid
stimulating
(TSH),
anti-müllerian
(AMH),
antral-follicle-count
duration
COS,
E2,
progesterone
last
monitoring,
TVUS
thickness
monitoring
before
OPU,
FOI
OPU.
Additionally,
number
meiosis
II
oocytes
retrieved
(MII),
total
dose
FSH
administered,
ratio
MII
OSI
registered.
Results
AMH
levels
significantly
lower
obese
compared
overweight
(1.05
IQR
1.20,
1.58
2.16,
1.32
1.38,
respectively,
p
-value
=
0.032).
When
looking
MII/FSH
ratio,
group
showed
median
value
3.3
an
4.0,
2.3
1.9,
had
2.6
2.8.
Those
data
statistically
significant
(
0.049).
Conclusion
These
results
emphasize
importance
considering
status
fertility
treatment
planning.
Genes,
Journal Year:
2023,
Volume and Issue:
15(1), P. 18 - 18
Published: Dec. 21, 2023
The
implementation
of
next
generation
sequencing
(NGS)
in
preimplantation
genetic
testing
for
aneuploidy
(PGT-A)
has
led
to
a
higher
prevalence
mosaic
diagnosis
within
the
trophectoderm
(TE)
sample.
Regardless,
mosaicism
could
potentially
increase
rate
live-born
children
with
chromosomic
syndromes,
though
available
data
from
transfer
embryos
putative
PGT-A
are
scarce
but
reassuring.
Even
lower
implantation
and
miscarriage
rates,
can
develop
into
healthy
live
births.
Therefore,
this
urges
an
explanation
disappearance
aneuploid
cells
throughout
development,
provide
guidance
management
clinical
practice.
Technical
overestimation
mosaicism,
together
some
sort
“self-correction”
mechanisms
during
early
post-implantation
stages,
emerged
as
potential
explanations.
Unlike
animal
model,
which
elimination
genetically
abnormal
future
fetal
lineage
been
demonstrated,
human
capability
remains
unverified
even
germ
layer
displays
aneuploidy-induced
cell
death
preference
rates
apoptosis
inner
mass
(ICM)
than
TE
cells.
Moreover,
reported
differential
dynamics
proliferation
between
euploid,
mosaic,
embryos,
pro-apoptosis
gene
products
(cfDNA
mRNA)
extracellular
vesicles
identified
blastocoel
fluid,
may
support
hypothesis
mechanism
purge
embryo
Alternative
hypotheses,
like
correction
by
extrusion
trisomy
chromosome
or
monosomic
duplication,
even,
they
represent
extremely
rare
phenomenon.
On
other
hand,
technical
limitations
analysis
lead
inaccuracy
diagnoses,
identifying
“mosaic”
those
that
uniformly
euploid
aneuploid.
NGS
assumption
“intermediate
copy
number
profiles”
evidence
mixture
single
biopsy
be
poorly
predictive
cases
diagnosis.
Additionally,
concordance
found
ICM
biopsies
displaying
is
expected,
it
correlates
differently
depending
on
type
(whole
versus
segmental)
level
reported.
Thus,
low-/medium-level
(<50%),
would
rarely
involve
regions.
However,
high-level
mosaics
(≥50%),
should
display
prevalence,
revealing
more
uniform
most
representing
variation
range,
therefore
might
impair
birth
rate.